We are live on
!
Find out more
Lilly Endowment Portfolio holdings
AUM
$108B
1-Year Est. Return
53.87%
This Fund
S&P 500
This Quarter
Est. Return
-2.12%
1 Year Est. Return
+53.87%
3 Year Est. Return
+155.75%
5 Year Est. Return
+422.58%
10 Year Est. Return
+1,423.09%
AUM
$72.9B
AUM Growth
-$1.99B
(-2.7%)
Cap. Flow
-$390M
Cap. Flow
% of AUM
-0.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$390M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.08T
| $72.9B | 100% |
95,492,993
-523,985
| -0.5% | -$390M |
|
Similar funds
Lilly Endowment's Q3 2025 Portfolio in Review
As of Q3 2025, Lilly Endowment held 1 position worth $72.9B, down 2.7% from $74.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 0%. Lilly Endowment opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Lilly Endowment's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $390M.
- Lilly Endowment's ten largest holdings make up 100% of its $72.9B portfolio in Q3 2025.
- Lilly Endowment opened 0 new positions and closed 0 in Q3 2025.
- Lilly Endowment's portfolio value fell 2.7% quarter-over-quarter to $72.9B.
Based on Lilly Endowment's 13F filing for Q3 2025, filed 31 Oct 2025.